Skip to content

Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure

Quality of Life Change in Patients Undergoing Parathyroidectomy With Secondary Hyperparathyroidism Due to End-stage Renal Failure: a Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06378931
Enrollment
80
Registered
2024-04-23
Start date
2024-04-15
Completion date
2025-12-30
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Failure, Secondary Hyperparathyroidism

Brief summary

The purpose of this study is to characterize the quality of life change in patients undergoing parathyroidectomy with secondary hyperparathyroidism due to end-stage renal failure.

Detailed description

Study participants will be asked questions about age, gender, education level, clinical symptoms, intensities of depression and anxiety, etc, and they will also be questioned regarding the prior quality of life score, as measured by the health-related quality of life 36-item Short-Form (SF-36) survey before surgery. Then, study participants will be contacted at one, three, six months, and 1 year after surgery, and asked questions about their SF-36 score, depression, and anxiety intensity.

Interventions

Study the progression of quality of life.

Sponsors

Chunling Jiang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: ≥18 years old; * Patients scheduled for parathyroidectomy with secondary hyperparathyroidism due to end-stage renal failure

Exclusion criteria

• Patients refuse to participate

Design outcomes

Primary

MeasureTime frameDescription
Measure quality of life scores change with respect to timeup to 1 yearQuality of life will be assessed by the 36-Item short form health survey scale, Subjects complete one response from a range of options for each of the 36 questions. A combination of item response is then aggregated to calculate a score for each of the eight dimensions listed. The scores for each dimension range from 0 to 100, with higher scores indicating better health status

Secondary

MeasureTime frameDescription
Measure anxiety and depression score change with respect to timeup to 1 yearThe anxiety and depression were evaluated using Hospital anxiety and depression Scale (HADS). The HADS consists of 14 questions, with 7 items each for the anxiety and depression subscales. The score for each item ranges from 0 to 3 points, and scores are summed to yield a separate score for anxiety (HADS-A) and depression (HADS-D).
Measure bone pain scores change with respect to timeup to 1 yearThe bone pain is evaluated using numerical rating scale (NRS). NRS scores range from 0 to 10 points, with 0 points representing no pain, 1-3 points representing mild pain, 4-6 points representing moderate pain, 7-9 points representing severe pain and 10 points representing the strongest pain.
Length of hospital staythrough study completion, an average of 1 weekDetermined by the number of days from admittance to discharge

Contacts

Primary ContactChunling Jiang, PhD
jiangchunling@scu.edu.cn18980601096
Backup ContactChunling Jiang

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026